ClinicalTrials.gg
CompletedNCT03361644Updated Apr 8, 2021

The Role of High Intensity Interval Training in the Treatment of Adolescent Obesity

An interventional study of High-Intensity Interval Training and Moderate-Intensity Continuous Training in Pediatric Obesity, Adolescent Obesity and Weight Loss, sponsored by Virginia Commonwealth University. Completed at 1 site in United States. Open to participants aged 12 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-08.

Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
12 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 12 studies in Pediatric Obesity by Virginia Commonwealth University — 1 open to participants now, 1 under way, none of them phase 3. Pediatric Obesity · Virginia Commonwealth University.

Enrollment
7th of 11
80 · median 110
Started
2018
with 1 other
No phase
11 of 12
1 open now
Registered
7th of 12
by date

Among the 12 studies in Pediatric Obesity by Virginia Commonwealth University, this one is the 7th largest by enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2018, is one of 11 with no phase, and was the 7th registered.

Pediatric Obesity

1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.

Browse Pediatric Obesity studies →

Open to participants now

1 of the 12 studies in Pediatric Obesity by Virginia Commonwealth University is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 124 Pediatric Obesity studies recruiting now, 19 (15%) set no upper age limit and 103 (83%) stop at 75 or younger; 114 take children under 18; 69 take healthy volunteers.

This study: 12 Years to 16 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Pediatric Obesity by Virginia Commonwealth University, or all of them as a file.
02

Study summary

The study will compare the effects of High Intensity Interval Training (HIIT) with Moderate Intensity Continuous Training (CMIT) as part of a lifestyle intervention program on BMI change in adolescents age 12-16 with obesity.

Read the detailed description

Adolescents will be randomized to a 12-week lifestyle intervention including behavioral and dietary interventions, and one of two exercise training conditions, HIIT or CMIT). Adolescents in the HIIT treatment will participate in treadmill exercise in 1-minute intervals of challenging intensities with recovery periods in between, gradually increasing the number of intervals over the course of the study. Adolescents in the CMIT treatment will participate in a constant moderate intensity treadmill exercise, gradually increasing the duration of the exercise over the course of the study.

Both parents and teens will have height and weight measurements taken, complete behavior questionnaires and wear an activity monitor for one week at baseline, 12 weeks and 16 weeks.

Adolescents will have a physical exam by a study medical provider before starting the intervention. Adolescents will also have blood work, an oral glucose tolerance test, an electrocardiogram, body composition measurements and a maximal graded exercise test done at baseline, and again at one or more time points. Adolescents will also complete a detailed food log at those time points.

Adolescents will exercise at the study gym 3 evenings a week for 12 weeks. On one of those evenings teens will also attend a 60-minute individual behavioral weight management session. Nine of these are with a behavior coach, and 3 with a dietitian. Parents will also attend one introductory session with the behavior coach, join the teen for the 3 sessions with the dietitian, and review adolescent individual goals and identify parent support goals at the end of each behavior session.

03

Conditions studied

  • Pediatric Obesity
  • Adolescent Obesity
  • Weight Loss
04

Who can participate

Ages eligible
12 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age of 12 to 16 years with obesity ( ≥95% percentile for age and gender according to the CDC Growth Charts).
  • Have a parent (or legal guardian) who is willing to provide basic demographic information, complete required surveys, and attend portions of the weekly adolescent-focused behavioral weight management sessions.
  • Participating parent must reside with the adolescent within a 30-mile distance of the study site.

Exclusion criteria

Exclusion Criteria:

  • Non-English speaking;
  • Weight >300 lbs;
  • Medical condition(s) that may be associated with unintentional weight change (e.g., hypothalamic injury, Prader-Willi, untreated thyroid disease or );
  • Diabetes mellitus diagnosed by history or a fasting glucose ≥126 mg/dl (subjects with glucose intolerance or "prediabetes" will eligible for study participation);
  • Use of insulin sensitizing agents (e.g. metformin), antihypertensive medications, medications for treatment of hyperlipidemia, oral , oral , atypical antipsychotics, weight loss medications, or an medication within 3 months of study participation;
  • Medical condition(s) that may be negatively impacted by high-intensity exercise training;
  • Psychiatric, cognitive, developmental or physical conditions that would impair the adolescent's ability to complete assessments, participate in behavioral weight management sessions, or conduct physical activity;
  • Reports of compensatory behaviors (i.e., vomiting, laxative abuse, excessive exercise) in the past 3 months;
  • Current pregnancy or plan to become pregnant during study period;
  • Previous participation in the TEENS study at Virginia Commonwealth University;
  • Current participation in another weight loss program; or
  • Personal history of weight loss surgery;
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    High-Intensity Interval Training

    Brief periods of vigorous physical activity separated by short periods of rest.

    Behavioral: High-Intensity Interval Training

  • Active comparator
    Moderate-Intensity Continuous Training

    Physical activity at a sustained moderate heart rate.

    Behavioral: Moderate-Intensity Continuous Training

Interventions

  • BehavioralHigh-Intensity Interval Training

    Participants assigned to HIIT will participate in treadmill exercise in intervals consisting of 1 minute intervals of challenging intensities with recovery periods in between, gradually increasing the number of intervals over the course of the study.

  • BehavioralModerate-Intensity Continuous Training

    Participants assigned to CMIT will participate in constant moderate intensity treadmill exercise, gradually increasing the duration of the exercise over the course of the study.

06

What researchers measure

Primary outcomes

  1. Cardiorespiratory fitness

    The two training methods will be compared for how they impact participants' fitness levels as assessed during a graded exercise tolerance test.

    Time frame: 12 weeks

Secondary outcomes

  1. Change in Body Mass Index (BMI)

    The two training methods will be compared for changes in participants' BMI in kg/m2

    Time frame: 12 weeks

  2. Change in Blood Lipid Levels

    The two training methods will be compared for changes in fasting lipid levels.

    Time frame: 12 weeks

  3. Change in Body Composition

    The two training methods will be compared for differences in changes of percent body fat.

    Time frame: 12 weeks

  4. Participant Attendance

    The two training methods will be compared for differences in rates of participant attendance at intervention sessions.

    Time frame: 12 weeks

  5. Achievement of Heart Rate Goals.

    The two training methods will be compared for differences in rates of achievement of heart rate goals during exercise training sessions.

    Time frame: 12 weeks

  6. Acceptability of exercise

    The two training methods will be compared for differences in participants' reported enjoyment of the exercise session.

    Time frame: 12 weeks

  7. Feasibility of Exercise

    The two training methods will be compared for differences in participants' confidence in being able ability to continue to participate in the assigned type of exercise.

    Time frame: 12 weeks

  8. Maintenance of lifestyle changes

    The two training methods will be compared for participants' frequency of participation in physical activity 1 month after completion of the intervention.

    Time frame: 16 weeks

  9. Weight loss maintenance

    The two training methods will be compared for changes in BMI 1 month after completion of the intervention.

    Time frame: 16 weeks.

07

Study locations

1 site
  • Children's Hospital of Richmond at VCU Healthy Lifestyles Center
    Henrico, Virginia 23239, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2018 to primary completion in Jan 2020, 23 months.

Of 539 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's 23 months is close to that.

Counting every sponsor, half of 541 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 17, 2017
First posted
Dec 5, 2017
StartActual
Feb 8, 2018
Primary completionActual
Jan 13, 2020
CompletionActual
Feb 20, 2020
Last update
Apr 8, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03361644
Responsible party
Sponsor
First posted
Dec 5, 2017
Start date
Feb 8, 2018
Primary completion
Jan 13, 2020
Completion
Feb 20, 2020
Last update
Apr 8, 2021

Study contacts

Edmond P Wickham, MD
principal investigator · VCU Departments of Pediatrics and Internal Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion